Six Benetas aged care homes in Melbourne and Geelong are set to participate in a pioneering study to assess the efficacy of ultraviolet (UV) light in reducing the impact of COVID-19 and flu. The Victorian Department of Health’s 12-month Elucidar study, beginning in early July, will involve over 60 aged care facilities.
The participating Benetas homes include The Views at Heidelberg, Clarinda on the Park, Colton Close (Glenroy), St George’s (Altona), Corowa Court (Mornington), and St Paul’s (Frankston). The trial will see UV lights installed in half of these homes, while the rest will serve as control sites.
Germicidal UV light, invisible and safe for use around residents and staff, is believed to neutralize airborne viruses. Data on respiratory infections, including COVID-19 and flu, will be collected across all facilities during the study.
“Aged care residents are particularly vulnerable to these illnesses. If UV lights can reduce their impact, it represents a significant advancement for the sector.”
Benetas CEO Sandra Hills OAM
Victorian Minister for Ageing Ingrid Stitt highlighted the broader implications, emphasising the study’s role in developing innovative methods to protect aged care communities.
The Burnet Institute, a key research partner, will lead the scientific and clinical trial efforts.
